US FDA Suggests Using ICH Drug Guidance To Meet Device Quality Requirements for Transdermals
Executive Summary
FDA’s draft guidance on transdermal and topical delivery systems says manufacturers can leverage pharmaceutical development studies principles for device design control requirements.